Compugen to Participate in Upcoming Investor Conferences
Compugen to Participate in Upcoming Investor Conferences [Accessibility Statement] Skip NavigationHOLON, Israel, Feb. 19, 2026 /PRNewswire/ -- [Compugen Ltd.](NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered by AI/ML, today announced that management will participate in the following upcoming investor conferences:Oppenheimer 36th Annual Healthcare Life Sciences ConferenceDate: Thursday, February 26, 2026Location: VirtualForm ...